IL17A and colorectal carcinoma: Chen and colleagues revealed that the presence of CMV in CRC tumors was associated with a worse outcome and an increased expression of interleukin-17 in elder patients [197], whereas a more favorable disease-free survival rate was reported in CMV-positive non-elderly (aged < 65 years) CRC patients, suggesting that there may be a possible age-dependent effect [61].